Abstract:BACKGROUND:Whole-exome sequencing can provide insight into the relationship between observed clinical phenotypes and underlying genotypes. METHODS:We conducted a retrospective analysis of data from a series of 7374 consecutive unrelated patients who had been referred to a clinical diagnostic laboratory for whole-exome sequencing; our goal was to determine the frequency and clinical characteristics of patients for whom more than one molecular diagnosis was reported. The phenotypic similarity between molecularly diagnosed pairs of diseases was calculated with the use of terms from the Human Phenotype Ontology. RESULTS:A molecular diagnosis was rendered for 2076 of 7374 patients (28.2%); among these patients, 101 (4.9%) had diagnoses that involved two or more disease loci. We also analyzed parental samples, when available, and found that de novo variants accounted for 67.8% (61 of 90) of pathogenic variants in autosomal dominant disease genes and 51.7% (15 of 29) of pathogenic variants in X-linked disease genes; both variants were de novo in 44.7% (17 of 38) of patients with two monoallelic variants. Causal copy-number variants were found in 12 patients (11.9%) with multiple diagnoses. Phenotypic similarity scores were significantly lower among patients in whom the phenotype resulted from two distinct mendelian disorders that affected different organ systems (50 patients) than among patients with disorders that had overlapping phenotypic features (30 patients) (median score, 0.21 vs. 0.36; P=1.77×10-7). CONCLUSIONS:In our study, we found multiple molecular diagnoses in 4.9% of cases in which whole-exome sequencing was informative. Our results show that structured clinical ontologies can be used to determine the degree of overlap between two mendelian diseases in the same patient; the diseases can be distinct or overlapping. Distinct disease phenotypes affect different organ systems, whereas overlapping disease phenotypes are more likely to be caused by two genes encoding proteins that interact within the same pathway. (Funded by the National Institutes of Health and the Ting Tsung and Wei Fong Chao Foundation.).

Functional categorization of gene regulatory variants that cause Mendelian conditions

Exploring noncoding variants in genetic diseases: From detection to functional insights

A cell type-aware framework for nominating non-coding variants in Mendelian regulatory disorders

Understanding genetic variants in context

Major Causes of Conflicting Interpretations of Variant Pathogenicity in Rare Disease: A Systematic Analysis

A systematic characterization of genes underlying both complex and Mendelian diseases.

Principles for the Post-Gwas Functional Characterisation of Risk Loci

Non-coding genetic variants in human disease

Methods for Functional Characterization of Genetic Polymorphisms of Non-Coding Regulatory Regions of the Human Genome

Rare and low-frequency variants in human common diseases and other complex traits

From variant to function in human disease genetics

Functional dissection of complex and molecular trait variants at single nucleotide resolution

Regulatory variants: from detection to predicting impact

Prediction of Functional Regulatory SNPs in Monogenic and Complex Disease.

The functional genomics laboratory: functional validation of genetic variants

Discordance between a deep learning model and clinical-grade variant pathogenicity classification in a rare disease cohort

Evaluation of phenotype-driven gene prioritization methods for Mendelian diseases

The functional impact of rare variation across the regulatory cascade

Resolution of Disease Phenotypes Resulting from Multilocus Genomic Variation.

Widespread Macromolecular Interaction Perturbations in Human Genetic Disorders

Decoding polygenic diseases: advances in noncoding variant prioritization and validation